Sun FDA Friday, May 25, 2012 0.00 Neutral

FDA Approves ABSORICA — Sun Pharmaceutical Industries, Inc.

Sun Pharmaceutical Industries’ 2012 approval of Absorica (isotretinoin) strengthened the company's market position in the dermatology sector by introducing a branded generic alternative, which intensified competition for established acne treatment providers.

View original filing at SEC.gov →

AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day